AI assistant
Sending…
ZEVRA THERAPEUTICS, INC. — Director's Dealing 2021
Dec 1, 2021
32811_dirs_2021-11-30_c0a0d6ff-4ec6-4fa7-bbe5-33b2ad9d9a7b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: KEMPHARM, INC (KMPH)
CIK: 0001434647
Period of Report: 2021-11-30
Reporting Person: Pascoe Richard W (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-30 | Common Stock | P | 1500 | $7.8814 | Acquired | 3285 | Direct |
More from ZEVRA THERAPEUTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Interim / Quarterly Report
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 20
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2